Drug repurposing through nonhypothesis driven phenotypic screening

The tremendous biological complexity associated with living systems results in significant limitations on the reductionist or target-based drug discovery approach.Increasingly it is being recognized that allowing for more serendipity to enter drug discovery vis-à-vis phenotypic screening provides for more cost-effective drug discovery with higher productivity. Several compelling studies and examples help establish this point of view.